Intended for healthcare professionals

Letters Prostate cancer screening

Underscreened and undertreated

BMJ 2011; 342 doi: (Published 14 June 2011) Cite this as: BMJ 2011;342:d3708
  1. Jesse N Aronowitz, physician1
  1. 1University of Massachusetts Medical School, Worcester, MA 01605-2397, USA
  1. aronowij{at}

Three points question Sandblom and colleagues’ conclusion that screening for prostate cancer conferred no significant survival benefit.1

  • (1) A quarter of the men randomised to the screening cohort did not attend. Two thirds of …

View Full Text

Log in

Log in through your institution


* For online subscription